Abstract We read with great interest the recent review by de Bakker et al that summarized the state of several existing and emerging technologies for estimating bone strength and fracture risk in vivo. Much of their review focused on how well the measurements of selected technologies predicted experimental measurements of bone strength by ex vivo quasistatic mechanical testing (QMT) and on how well they tracked changes in mechanical properties of bone. The authors noted that the association of many common skeletal health measurements (e.g., DXA measures of trabecular bone score and areal and volumetric BMD) are only moderately associated with bone strength. The authors did not include mechanical response tissue analysis (MRTA) in their review. MRTA is a dynamic mechanical bending test that uses a vibration analysis technique to make immediate, direct, functional measurements of the mechanical properties (mass, stiffness, and damping) of long bones in humans in vivo. In this article we note our interest in the ability of MRTA to detect large changes in bone stiffness that go undetected by DXA. We also highlight results of our proprietary improvements to MRTA technology that have resulted in unmatched accuracy in QMTvalidated measurements of the bending stiffness and estimates of the bending strength (both R2 = 0.99) of human ulna bones. To distinguish our improved technique from the legacy MRTA technology, we refer to it as Cortical Bone Mechanics Technology (CBMT). Further research will determine whether such CBMT measurements are clinically useful.
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Cortical bone mechanics technology
We read with great interest the recent review by de Bakker et al. that summarized the state of several existing and emerging technologies for estimating bone strength and fracture risk in vivo [1] . We commend the authors for a well-written review of DXA-based bone mineral density (BMD), imaging-based structural measurements, and finite element analysis-based techniques, as well as alternate methods including quantitative ultrasound (QUS), bone biopsy, reference point indentation (RPI), and statistical shape and density modeling. Much of their review focused on how well the measurements of these technologies predicted experimental measurements of bone strength by ex vivo quasistatic mechanical testing (QMT) and on how well they tracked changes in mechanical properties of bone. The authors noted that the association of DXA measures of trabecular bone score and areal and volumetric BMD, QUS measures of speed of sound and broadband attenuation, and RPI-derived measure of indentation increase with bone strength was moderate at best (R 2 values in the 0.20 to 0.67 range).
The authors did not include mechanical response tissue analysis (MRTA) in their review. MRTA is a dynamic mechanical bending test that uses a vibration analysis technique to make immediate, direct, functional measurements of the mechanical properties (mass, stiffness, and damping) of long bones in humans in vivo. The basic technique was invented 30 years ago at Stanford University [2] and developed with support from NASA, but its commercialization was blocked by the rapid adoption of DXA in the 1990s. The 20-year history of legacy MRTA devices used in experimental and clinical research has been described elsewhere [3] . Especially intriguing to us was its ability to detect large (~25%) changes in bone stiffness in response to short periods (20 weeks) of resistance exercise [4, 5] and to selective experimental degradation of collagen by potassium hydroxide (KOH) [6] . The latter ex vivo finding was confirmed by QMT and went undetected by DXA and QUS.
Several years ago, we noted a declining confidence in DXA due to its poor performance in predicting fractures in prospective studies [7] [8] [9] : most patients diagnosed with osteoporosis do not fracture and most fractures occur in patients who do not have osteoporosis. We also noted an increasing clinical interest in cortical bone, because after age 60, most bone lost is cortical and most fractures occur at sites with large amounts of cortical bone [10] . Because MRTA is specifically sensitive to cortical bone mechanics, we decided to investigate whether MRTA might be further developed.
Since then, our proprietary improvements to the legacy MRTA technology have enabled us to achieve unmatched accuracy in QMT-validated measurements of the bending stiffness (R 2 = 0.999) of 39 artificial human ulna bones [11] , and most recently in QMT-validated measurements of the bending stiffness and estimates of the bending strength (both R 2 = 0.99) of ulna bones within 35 cadaveric human arms from donors ranging widely in age (17-99 years) and BMI (13-40 kg/m 2 ). To distinguish our improved technique from the legacy MRTA technology, we refer to it as Cortical Bone Mechanics Technology (CBMT). Further research will determine whether such CBMT measurements are clinically useful.
Again, we commend de Bakker and colleagues for their recent review and appreciate this opportunity to supplement it.
